Learn more about whether Ocular Therapeutix, Inc. or Organon & Co. is a better investment based on AAII's A+ Investor grades, ...

Rocket Pharmaceuticals' shares rallied ahead of the opening bell after the Food and Drug Administration lifted its clinical hold on the biotechnology company's Phase 2 trial of its RP-A501 treatment ...